NovoCure Limited (NVCR) DCF Valuation

NovoCure Limited (NVCR) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

NovoCure Limited (NVCR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insights into your NovoCure Limited (NVCR) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with actual NVCR data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of NovoCure Limited.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 351.3 494.4 535.0 537.8 509.3 565.6 628.0 697.4 774.4 859.9
Revenue Growth, % 0 40.72 8.23 0.52502 -5.3 11.04 11.04 11.04 11.04 11.04
EBITDA 14.2 45.3 -38.4 -63.1 -175.9 -45.5 -50.5 -56.1 -62.3 -69.2
EBITDA, % 4.05 9.16 -7.17 -11.73 -34.53 -8.05 -8.05 -8.05 -8.05 -8.05
Depreciation 8.4 9.2 10.3 10.6 11.0 11.6 12.9 14.3 15.9 17.7
Depreciation, % 2.39 1.85 1.92 1.98 2.15 2.06 2.06 2.06 2.06 2.06
EBIT 5.8 36.2 -48.6 -73.7 -186.8 -57.1 -63.4 -70.5 -78.2 -86.9
EBIT, % 1.66 7.31 -9.09 -13.71 -36.68 -10.1 -10.1 -10.1 -10.1 -10.1
Total Cash 326.1 842.6 937.7 969.4 910.6 557.5 619.0 687.4 763.3 847.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 58.9 96.7 93.6 86.3 61.2
Account Receivables, % 16.75 19.56 17.49 16.04 12.02
Inventories 23.7 27.4 24.4 29.4 38.2 33.7 37.4 41.6 46.2 51.3
Inventories, % 6.75 5.55 4.57 5.46 7.49 5.96 5.96 5.96 5.96 5.96
Accounts Payable 36.9 53.6 72.6 85.2 94.4 78.4 87.1 96.7 107.3 119.2
Accounts Payable, % 10.51 10.85 13.57 15.84 18.53 13.86 13.86 13.86 13.86 13.86
Capital Expenditure -10.5 -15.0 -24.2 -21.4 -27.1 -22.4 -24.9 -27.6 -30.7 -34.1
Capital Expenditure, % -2.98 -3.03 -4.52 -3.97 -5.32 -3.96 -3.96 -3.96 -3.96 -3.96
Tax Rate, % -7.98 -7.98 -7.98 -7.98 -7.98 -7.98 -7.98 -7.98 -7.98 -7.98
EBITAT 4.8 39.6 -54.5 -83.4 -201.7 -55.1 -61.2 -67.9 -75.4 -83.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -43.0 8.9 -43.3 -79.1 -192.4 -108.8 -78.4 -87.1 -96.7 -107.4
WACC, % 7.14 7.26 7.26 7.26 7.26 7.24 7.24 7.24 7.24 7.24
PV UFCF
SUM PV UFCF -389.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -110
Terminal Value -2,090
Present Terminal Value -1,474
Enterprise Value -1,863
Net Debt 355
Equity Value -2,218
Diluted Shares Outstanding, MM 106
Equity Value Per Share -20.85

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: NovoCure’s financial data pre-loaded to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing time efficiency.

Key Features

  • Accurate NovoCure Financials: Gain access to reliable pre-loaded historical data and future forecasts.
  • Tailored Forecast Assumptions: Modify highlighted cells such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
  • Designed for All Levels: An intuitive layout suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the pre-prepared Excel file containing NovoCure Limited’s (NVCR) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and evaluate outcomes instantly.
  • Make Decisions: Leverage the valuation results to inform your investment strategy.

Why Choose This Calculator for NovoCure Limited (NVCR)?

  • Accuracy: Utilizes real NovoCure financials for precise data representation.
  • Flexibility: Allows users to experiment and adjust inputs effortlessly.
  • Time-Saving: Avoid the complexity of constructing a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.

Who Should Use NovoCure Limited (NVCR)?

  • Investors: Gain insights into innovative cancer treatments and make informed investment choices.
  • Healthcare Analysts: Utilize comprehensive data to evaluate NovoCure's market position and growth potential.
  • Consultants: Tailor presentations for clients interested in biotechnology and healthcare advancements.
  • Medical Researchers: Explore the latest developments in tumor treatment technologies and their implications.
  • Students and Educators: Leverage real-world case studies for a deeper understanding of the biotech industry.

What the Template Contains

  • Preloaded NVCR Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.